Fieldpoint Private Securities, LLC Novo Cure LTD Transaction History
Fieldpoint Private Securities, LLC
- $344 Million
- Q2 2022
A detailed history of Fieldpoint Private Securities, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Fieldpoint Private Securities, LLC holds 801 shares of NVCR stock, worth $12,503. This represents 0.02% of its overall portfolio holdings.
Number of Shares
801
Previous 803
0.25%
Holding current value
$12,503
Previous $67,000
16.42%
% of portfolio
0.02%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding NVCR
# of Institutions
272Shares Held
77.2MCall Options Held
751KPut Options Held
293K-
Black Rock Inc. New York, NY12.1MShares$189 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA11.7MShares$183 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$174 Million0.0% of portfolio
-
State Street Corp Boston, MA3.01MShares$46.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.38MShares$37.1 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.64B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...